rs1064875
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_022468.5(MMP25):c.661+1662G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.213 in 151,798 control chromosomes in the GnomAD database, including 3,563 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.21 ( 3562 hom., cov: 30)
Exomes 𝑓: 0.14 ( 1 hom. )
Consequence
MMP25
NM_022468.5 intron
NM_022468.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.00900
Publications
15 publications found
Genes affected
MMP25 (HGNC:14246): (matrix metallopeptidase 25) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMPs are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP (MT-MMP) subfamily, attached to the plasma membrane via a glycosylphosphatidyl inositol anchor. In response to bacterial infection or inflammation, the encoded protein is thought to inactivate alpha-1 proteinase inhibitor, a major tissue protectant against proteolytic enzymes released by activated neutrophils, facilitating the transendothelial migration of neutrophils to inflammatory sites. The encoded protein may also play a role in tumor invasion and metastasis through activation of MMP2. The gene has previously been referred to as MMP20 but has been renamed MMP25. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.24 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MMP25 | NM_022468.5 | c.661+1662G>A | intron_variant | Intron 4 of 9 | ENST00000336577.9 | NP_071913.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MMP25 | ENST00000336577.9 | c.661+1662G>A | intron_variant | Intron 4 of 9 | 1 | NM_022468.5 | ENSP00000337816.4 |
Frequencies
GnomAD3 genomes AF: 0.213 AC: 32334AN: 151618Hom.: 3556 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
32334
AN:
151618
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.141 AC: 9AN: 64Hom.: 1 Cov.: 0 AF XY: 0.146 AC XY: 7AN XY: 48 show subpopulations
GnomAD4 exome
AF:
AC:
9
AN:
64
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
48
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
AC:
1
AN:
6
European-Finnish (FIN)
AF:
AC:
1
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
6
AN:
48
Other (OTH)
AF:
AC:
1
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.213 AC: 32346AN: 151734Hom.: 3562 Cov.: 30 AF XY: 0.212 AC XY: 15729AN XY: 74142 show subpopulations
GnomAD4 genome
AF:
AC:
32346
AN:
151734
Hom.:
Cov.:
30
AF XY:
AC XY:
15729
AN XY:
74142
show subpopulations
African (AFR)
AF:
AC:
9565
AN:
41296
American (AMR)
AF:
AC:
3755
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
AC:
693
AN:
3468
East Asian (EAS)
AF:
AC:
983
AN:
5154
South Asian (SAS)
AF:
AC:
943
AN:
4804
European-Finnish (FIN)
AF:
AC:
1796
AN:
10546
Middle Eastern (MID)
AF:
AC:
71
AN:
292
European-Non Finnish (NFE)
AF:
AC:
13927
AN:
67936
Other (OTH)
AF:
AC:
404
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1272
2544
3815
5087
6359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
611
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.